Document |
Document Title |
JP5082424B2 |
|
JP5077797B2 |
|
JP5076103B2 |
|
JP5075828B2 |
The use as fragrance ingredient of a compound of formula (I) wherein R1 and Y have the same meaning as given in the description, and fragrance applications comprising them.
|
JP5075192B2 |
A process for producing an alkenyl alcohol from a diol is disclosed. The process comprises dehydrating a diol in the presence of a catalyst comprising cerium oxide supported on a carrier. The carrier has a surface area in the range of 0....
|
JP5072026B2 |
|
JP5065872B2 |
To provide a heteropolyoxo methalate compound catalyst which can be used for an acid-base reaction, an oxide decomposition reaction and an oxidation reaction. The heteropolyoxo methalate compound catalyst is a catalyst for a specific rea...
|
JP2012211162A |
To provide compounds useful as Interleukin-1 and Tumor Necrosis Factor-α modulators, and thus useful in the treatment of various diseases.Analogous compounds using an acanthoic acid of formula (I) has as a prototype the therapeutic effect.
|
JP5059996B2 |
A compound having the following chemical structure: its produg esters and acid-addition salts, useful as Interleukin-1 and Tumor Necrosis Factor-± modulators, wherein R groups are defined in the claims.
|
JP5061632B2 |
A method of producing an o-disubstituted aromatic compound, containing: continuously conducting at least the following steps (a) to (d): (a) a step of mono-lithiating one halogen atom of an o-dihaloaromatic compound, using a first micror...
|
JP5059779B2 |
4-Aminopicolinic acids having tri- and tetra-substituted aryl substituents in the 6-position, and their amine and acid derivatives of the formula I are potent herbicides demonstrating a broad spectrum of weed control.
|
JP5059294B2 |
The present invention is directed to a reagent for use in the preparation of organomagnesium compounds as well as to a method of preparing such organomagnesium compounds. The present invention furthermore provides a method of preparing f...
|
JP2012524044A |
The present invention concerns a process for synthesis of 2,4,6-octatriene-1-oic acid and 2,4,6-octatriene-1-ol, which comprises the following stages: a) reaction between 2,4-trans-hexadienal and triethyl phosphonoacetate to give ethyl 2...
|
JP5043645B2 |
The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and...
|
JP5042434B2 |
A process produces an organic compound by allowing (A) a compound capable of generating a free radical to react with (B) at least one of esters and salts of nitrous acid in the presence of a nitrogen-containing cyclic compound constituti...
|
JP5042874B2 |
The present invention provides a communication terminal configured as a Mobile Node, MN, for use in network system that supports mobile Internet communication and has a plurality of Routers each having a unique communication address via ...
|
JP5041501B2 |
|
JP5040005B2 |
Manufacture of a fluorine-containing norbornene derivative having a fluorine-containing ketone structure comprises reacting a norbornene derivative and a fluoroalkylating agent. Manufacture of a fluorine-containing norbornene derivative ...
|
JP5036932B2 |
The production process of the present invention comprises a step of allowing a carboxylic acid derivative represented by the formula (1): wherein ring Z is a monocyclic or polycyclic non-aromatic or aromatic ring, and R<1> is a halogen a...
|
JP5028730B2 |
To provide a method for producing a methylbenzyl alcohol with a fluorinated nucleus, capable of being industrially conducted. This method for producing the methylbenzyl alcohol with a fluorinated nucleus comprises subjecting one of two h...
|
JP5029000B2 |
|
JP5030222B2 |
To provide a photocatalytic microreaction apparatus capable of effectively elevating the proportion of even a liquid raw material having low affinity for a photocatalyst and existing on the photocatalyst surface within a microchannel and...
|
JP2012521382A |
where at least one ortho position of the two phenyl rings in the formula (II) or the phenyl ring in the formula (I) must be substituted by a secondary or tertiary radical.
|
JP2012521409A |
The present invention relates to certain derivatives of 2-ethyl-4-(2′,2′-dimethyl-3′-alkyl-3′-cyclopenten-1â
€²-yl)-4-penten-1-ol. These compounds possess very interesting perfuming ingredients due to their unusual combination of...
|
JP2012176928A |
To provide pyrene derivatives having a new structure and new properties.There are provided pyrene derivatives represented by chemical formula (I) synthesized from a compound of chemical formula (II) and a compound of chemical formula (II...
|
JP5023683B2 |
|
JP5021879B2 |
The invention concerns a method for selectively extracting furan lipids and polyhydroxylated fatty alcohols of avocado, characterised in that it comprises steps which consist in: preparing an unsaponifiable matter of avocado; then in sub...
|
JP5018743B2 |
A fluorine-containing compound represented by the formula 1, where R1 is a methyl group or trifluoromethyl group, each of R2 and R3 is independently a hydrogen atom or a group containing (a) a hydrocarbon group having a straight-chain, b...
|
JP5008800B2 |
|
JP5000251B2 |
|
JP5000331B2 |
|
JP5001861B2 |
Method of asymmetrically hydrosilylating substrates using catalysts having a ligand of the compound of the formula (I) wherein R is optionally substituted alkyl, cycloalkyl, aryl or heteroaryl; R′ is hydrogen, optionally substituted lo...
|
JP5003172B2 |
|
JP4997732B2 |
|
JP4991049B2 |
The invention relates to phospholipid-like compounds having defined apolar constituents and to the use of such compounds as liposomes, active ingredients, and solubilizers.
|
JP4990937B2 |
Vitamin D derivatives having general formula (1) which are hydroxylated at the 24-position and considered as one of metabolites of physiologically active vitamin D derivatives substituted at the 2 beta -position wherein R1, R2, R3 and R4...
|
JP4989482B2 |
Biphenyl derivatives (I) are used in preparation of a drug to prevent and/or treat retinopathy. Biphenyl derivatives of formula (I) and their tautomeric forms, enantiomers, diastereoisomers, epimers and salts are used in preparation of a...
|
JP4984940B2 |
|
JP4984737B2 |
|
JP2012131727A |
To provide a method for easily producing a fluorine-containing compound high in safety, through enabling various kinds of solvents to be used, and with no need of any operation of extracting the product after reaction.The method comprise...
|
JP4970958B2 |
The present invention relates to a method comprising the step of contacting under hydroaminomethylation conditions, an olefin, an amine, a rhodium-phosphorous ligand, and synthesis gas (syngas). In particular, it has been discovered that...
|
JP4964789B2 |
The present invention generally relates to methods of inhibiting ethylene responses in plants and plant materials, and particularly relates to methods of inhibiting various ethylene responses including plant maturation and degradation, b...
|
JP4966449B2 |
A process for separating at least one component of a mixture in a set of closed-loop chromatographic columns is described, whereby the loop comprises at least one feedstock injection point, a raffinate draw-off point, an eluant injection...
|
JP4960886B2 |
2-Butene-1.4-diol can be prepared by hydrogenating 2-butyne-1,4-diol in the presence of a structured catalyst in the absence of a solvent.
|
JP4958374B2 |
Catalyst for the asymmetric (transfer) hydrogenation represented by the formula MLaXbSc, where M is a transition metal, to be chosen from rhodium and ruthenium, and X is a counter ion and S is a ligand, a ranges from 0.5 to 3 and b and c...
|
JP4955213B2 |
Asymmetric fluorene compounds are formed by reacting an amide starting material; reacting the resultant ketone with a further equivalent of a different organometallic reagent; and a ring closing elimination reaction. Formation of a compo...
|
JP2012513445A |
Chiral compounds of the formula (1), which are optically pure or highly optically enriched in which R 0 is C 1 -C 12 -alkyl which is unsubstituted or substituted by 1 to 2 C 1 -C 4 -alkoxy; cyclopentyl or cyclohexyl, which is unsubstitut...
|
JP2012513481A |
The invention features a series of heterocyclic derivatives that inhibit tumor necrosis factor alpha (TNF-±) induced necroptosis. The heterocyclic compounds of the invention are described by Formulas (I)-(VIII) and by Compounds (I)-(I),...
|
JP2012111717A |
To provide a method for obtaining a compound containing a dichloromethyl group from a compound containing a trichloromethyl group, capable of efficiently eliminating chlorine by cutting one carbon-chlorine bond in the trichloromethyl gro...
|
JP4948030B2 |
|